Abbott Laboratories (ABT)

110.11
+0.15(+0.14%)
  • Volume:
    420,188
  • Day's Range:
    109.96 - 110.62
  • 52 wk Range:
    101.24 - 142.60

ABT Overview

Prev. Close
109.96
Day's Range
109.96-110.62
Revenue
44.51B
Open
110.47
52 wk Range
101.24-142.6
EPS
4.83
Volume
420,188
Market Cap
192.86B
Dividend (Yield)
1.88
(1.71%)
Average Volume (3m)
4,660,313
P/E Ratio
22.53
Beta
0.699
1-Year Change
-11.27%
Shares Outstanding
1,751,219,743
Next Earnings Date
18 Oct 2022
What is your sentiment on Abbott Labs?
or
Vote to see community's results!

Abbott Laboratories News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Abbott Laboratories Analysis

Abbott Laboratories Company Profile

Abbott Laboratories Company Profile

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyNeutralBuySellNeutral
Technical IndicatorsStrong BuyStrong BuySellBuyStrong Sell
SummaryStrong BuyBuyNeutralNeutralSell
  • trump sign 750 million deal with Abbott will go up??
    1
    • 750M deal and the company is valued at 196B... use your brain
      1
    • Yeah! It will go up a lot! Like 2%!
      0